Total Payments
$330.69
2024 Payments
$95.91
Companies
14
Transactions
22
Medicare Patients
2,743
Medicare Billing
$225,406
Payment Breakdown by Category
Food & Beverage$330.69 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $330.69 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $61.50 | 4 | $0 (2024) |
| Novo Nordisk Inc | $58.00 | 4 | $0 (2024) |
| Seqirus USA Inc | $40.45 | 2 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $27.37 | 2 | $0 (2022) |
| Exact Sciences Corporation | $16.95 | 1 | $0 (2023) |
| IRONSHORE PHARMACEUTICALS INC. | $16.75 | 1 | $0 (2024) |
| PFIZER INC. | $15.16 | 1 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $14.66 | 1 | $0 (2022) |
| SANOFI PASTEUR INC. | $14.61 | 1 | $0 (2023) |
| Abbott Laboratories | $14.00 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $95.91 | 6 | ABBVIE INC. ($34.99) |
| 2023 | $66.82 | 4 | Seqirus USA Inc ($20.56) |
| 2022 | $91.08 | 6 | E.R. Squibb & Sons, L.L.C. ($27.37) |
| 2021 | $76.88 | 6 | AbbVie Inc. ($26.51) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Obesity | ||||||
| 11/14/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $16.75 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 07/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Respiratory | ||||||
| 03/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2023 | Seqirus USA Inc | Fluad Quadrivalent (Biological), FLUCELVAX QUADRIVALENT | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Vaccines | ||||||
| 10/27/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Diabetes | ||||||
| 05/08/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Oncology | ||||||
| 03/23/2023 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE HIGH-DOSE, FLUZONE QUADRIVALENT NORTHERN HEMISPHERE | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Vaccines | ||||||
| 10/25/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Diabetes Care | ||||||
| 07/13/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/21/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Cardio-renal | ||||||
| 05/05/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.37 | General |
| Category: Cardiovascular | ||||||
| 04/29/2022 | Seqirus USA Inc | FLUCELVAX QUADRIVALENT (Biological), Fluad Quadrivalent | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Vaccines | ||||||
| 02/17/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.00 | General |
| Category: Cardiovascular | ||||||
| 11/11/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/23/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/26/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: PRIMARY CARE | ||||||
| 08/13/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Diabetes | ||||||
| 05/17/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 787 | 1,209 | $127,067 | $65,648 |
| 2022 | 18 | 756 | 1,061 | $104,833 | $56,634 |
| 2021 | 15 | 644 | 1,002 | $106,857 | $56,365 |
| 2020 | 11 | 556 | 961 | $103,794 | $46,758 |
Total Patients
2,743
Total Services
4,233
Medicare Billing
$225,406
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 159 | 308 | $46,200 | $22,488 | 48.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 92 | 92 | $12,420 | $9,581 | 77.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 119 | 162 | $18,630 | $8,141 | 43.7% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 53 | 131 | $13,755 | $7,788 | 56.6% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 26 | 102 | $14,790 | $7,742 | 52.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 19 | $3,525 | $1,805 | 51.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 47 | 49 | $3,185 | $1,696 | 53.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 22 | 22 | $1,892 | $1,606 | 84.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 82 | 82 | $1,640 | $1,201 | 73.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 12 | 12 | $1,320 | $806.76 | 61.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $875.00 | $709.58 | 81.1% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 11 | 13 | $1,235 | $595.20 | 48.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 13 | 28 | $980.00 | $454.16 | 46.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 21 | 22 | $1,540 | $271.84 | 17.7% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 12 | 12 | $1,500 | $253.76 | 16.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 27 | 29 | $1,595 | $200.48 | 12.6% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 24 | 40 | $400.00 | $157.60 | 39.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 16 | $640.00 | $135.45 | 21.2% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 11 | 45 | $945.00 | $16.16 | 1.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 169 | 232 | $26,680 | $13,259 | 49.7% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 63 | 179 | $18,795 | $10,032 | 53.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 77 | 119 | $17,850 | $9,137 | 51.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 77 | 77 | $10,395 | $8,194 | 78.8% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 28 | 52 | $7,020 | $4,427 | 63.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 48 | 48 | $5,280 | $3,097 | 58.7% |
About Julie Moenter, P.A
Julie Moenter, P.A is a Medical healthcare provider based in Van Wert, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/24/2013. The National Provider Identifier (NPI) number assigned to this provider is 1023444965.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Julie Moenter, P.A has received a total of $330.69 in payments from pharmaceutical and medical device companies, with $95.91 received in 2024. These payments were reported across 22 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($330.69).
As a Medicare-enrolled provider, Moenter has provided services to 2,743 Medicare beneficiaries, totaling 4,233 services with total Medicare billing of $225,406. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Van Wert, OH
- Active Since 09/24/2013
- Last Updated 01/27/2016
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1023444965
Products in Payments
- ELIQUIS (Drug) $42.53
- UBRELVY (Drug) $41.75
- Ozempic (Drug) $28.85
- Fluad Quadrivalent (Biological) $20.56
- FLUCELVAX QUADRIVALENT (Biological) $19.89
- QULIPTA (Drug) $19.75
- Cologuard Collection Kit (Device) $16.95
- JORNAY PM (Drug) $16.75
- Rybelsus (Drug) $14.70
- Kerendia (Drug) $14.66
- FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological) $14.61
- Wegovy (Drug) $14.45
- FREESTYLE LIBRE 2 (Device) $14.00
- XARELTO (Drug) $13.89
- AIRSUPRA (Drug) $13.45
- DEXCOM G6 TRANSMITTER (Device) $12.52
- NURTEC ODT (Drug) $11.38
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.